Daily Financial Update Market Pulse: U.S. benchmarks drifted in a narrow range yesterday, buoyed by...
Author - Franklin Jay
RARE: Positive DTX301 Phase 3 Results Spark Investor Interest!
Overview of DTX301 Phase 3 Breakthrough Ultragenyx Pharmaceutical (NASDAQ: RARE), a biotech focused...
Global Chip Shakeup Sparks AI and Market Moves
Morning Brief Market Pulse: Markets shrugged off jitters, leaving growth names with modest gains...
QURE: FDA Delay Sparks 49% Drop—Investors, Act Now!
uniQure N.V. (NASDAQ: QURE) – a gene therapy developer – saw its stock price collapse almost in...
Unlock Gains in AI, Robotics and Supply-Chain Stocks
Opening Recap Market Pulse: Markets edged mixed yesterday as tech’s recent winners cooled off while...
Guggenheim Boosts AZN Price Target Before Q1 Earnings!
Guggenheim Securities recently raised its price target on AstraZeneca PLC (AZN) ahead of the...
Donut Labs Battery Skepticism Meets Physical AI Revolution
Opening Recap Market Pulse: Markets drifted to a mixed Friday finish as the S&P eked out small...
SLB Partners with Nvidia: A Game-Changer Ahead!
Overview: SLB’s Digital Pivot and Nvidia Partnership SLB (formerly Schlumberger) has been...
AI Chip Boom Sparks Robotics Stocks Rally
Opening Recap Market Pulse: U.S. stocks edged higher in thin end-of-week trading, buoyed by hefty...
IDE: FDA Filing Could Propel Glucotrack to 2025 Success!
GlucoTrack, Inc. (NASDAQ: GCTK) is a medical technology company developing innovative glucose...
